CN101217948A - 包含依匹那丁的透皮吸收眼科制剂 - Google Patents

包含依匹那丁的透皮吸收眼科制剂 Download PDF

Info

Publication number
CN101217948A
CN101217948A CNA200680024979XA CN200680024979A CN101217948A CN 101217948 A CN101217948 A CN 101217948A CN A200680024979X A CNA200680024979X A CN A200680024979XA CN 200680024979 A CN200680024979 A CN 200680024979A CN 101217948 A CN101217948 A CN 101217948A
Authority
CN
China
Prior art keywords
eye
preparation
formulation
epinastine
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200680024979XA
Other languages
English (en)
Chinese (zh)
Inventor
礒脇明治
中岛朋子
大鸟聪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of CN101217948A publication Critical patent/CN101217948A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNA200680024979XA 2005-07-08 2006-07-07 包含依匹那丁的透皮吸收眼科制剂 Pending CN101217948A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69736905P 2005-07-08 2005-07-08
US60/697,369 2005-07-08

Publications (1)

Publication Number Publication Date
CN101217948A true CN101217948A (zh) 2008-07-09

Family

ID=37016261

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200680024979XA Pending CN101217948A (zh) 2005-07-08 2006-07-07 包含依匹那丁的透皮吸收眼科制剂

Country Status (6)

Country Link
US (1) US20090143359A1 (enExample)
EP (1) EP1901724A1 (enExample)
JP (1) JP2009500397A (enExample)
KR (1) KR20080034916A (enExample)
CN (1) CN101217948A (enExample)
WO (1) WO2007007851A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116744904A (zh) * 2020-12-24 2023-09-12 参天制药株式会社 含有依匹斯汀或其盐和硫系抗氧化剂的经皮施予用医药组合物

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090042956A (ko) * 2006-08-28 2009-05-04 센주 세이야꾸 가부시키가이샤 안과 경피 흡수형 제제
ES2752008T3 (es) * 2009-10-30 2020-04-02 Intratus Inc Métodos y composiciones para la liberación sostenida de fármacos
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
US8900626B2 (en) 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
JP7599838B2 (ja) * 2019-04-10 2024-12-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性医薬組成物
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
CN116669705A (zh) * 2020-12-24 2023-08-29 参天制药株式会社 含有依匹斯汀或其盐的涂布施予用医药组合物
WO2022138826A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩を含有する塗布投与用医薬組成物
WO2025205960A1 (ja) * 2024-03-27 2025-10-02 参天製薬株式会社 エピナスチン又はその塩を含有する経皮投与用医薬組成物と抗アレルギー薬との組み合わせ

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3008944A1 (de) * 1980-03-08 1981-09-24 C.H. Boehringer Sohn, 6507 Ingelheim Dibenzimidazoazepine, ihre herstellung und verwendung
DE19542281C2 (de) * 1995-11-14 1997-12-04 Boehringer Ingelheim Kg Verwendung von Epinastin für die Behandlung der Migräne
RU2125427C1 (ru) * 1998-05-27 1999-01-27 Миронова Эмилия Михайловна Средство для лечения глазных заболеваний - оковидит
TWI233810B (en) * 1999-02-19 2005-06-11 Hisamitsu Pharmaceutical Co A paster sheet
WO2001026648A1 (en) * 1999-10-13 2001-04-19 Senju Pharmaceutical Co., Ltd. Ophthalmic adhesive preparations for percutaneous absorption
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10060852A1 (de) * 2000-12-06 2002-06-20 Hexal Ag Absorptionsmittel und Kanalbildner enthaltende wirkstoffundurchlässige Deckschicht oder abziehbare Schutzschicht eines transdermalen therapeutischen Systems
US6659985B2 (en) * 2002-01-30 2003-12-09 Southern College Of Optometry Method to use transdermal administration of androgens to the adnexa of the eye
EP1591110B1 (en) * 2003-01-22 2015-03-18 Senju Pharmaceutical Co., Ltd. Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
US20040247686A1 (en) * 2003-04-04 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising epinastine for the treatment of skin diseases
JP5315051B2 (ja) * 2005-07-08 2013-10-16 千寿製薬株式会社 オロパタジンを含む眼科用経皮吸収型製剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116744904A (zh) * 2020-12-24 2023-09-12 参天制药株式会社 含有依匹斯汀或其盐和硫系抗氧化剂的经皮施予用医药组合物

Also Published As

Publication number Publication date
US20090143359A1 (en) 2009-06-04
KR20080034916A (ko) 2008-04-22
EP1901724A1 (en) 2008-03-26
JP2009500397A (ja) 2009-01-08
WO2007007851A1 (en) 2007-01-18

Similar Documents

Publication Publication Date Title
EP2493474B1 (en) Methods and compositions for sustained delivery of drugs
JP5020061B2 (ja) 経皮吸収型製剤
EP0974350A1 (en) External preparation containing tranilast and process for producing the same
EP1150675B1 (en) A transdermal composition of an antivomiting agent and a preparation containing the same
EP1754491B1 (en) Ophthalmic percutaneously absorbed preparation containing muscarinic receptor agonist
CN101217948A (zh) 包含依匹那丁的透皮吸收眼科制剂
CN101217937A (zh) 包含奥洛他定的透皮吸收眼科制剂
TW201940159A (zh) 經皮吸收型製劑
WO2005102306A1 (ja) 消炎鎮痛貼付剤
JPWO2017006974A1 (ja) 経皮吸収型貼付剤
TW201002313A (en) Antipruritic and analgesic medicine containing oxybuprocaine for external use
KR20070018755A (ko) 무스카린 수용체 작동약을 함유한 안과용 경피흡수형 제제
CA2244679C (en) Tranilast-containing preparation for external application and method of producing the same
EP1917964A1 (en) Percutaneously absorbable ophthalmic preparation
JPWO2016052617A1 (ja) ナルフラフィン含有局所適用製剤
HK1175119A (en) Methods and compositions for sustained delivery of drugs
HK1175119B (en) Methods and compositions for sustained delivery of drugs
HK1193996A (en) Adhesive skin patch containing serotonin receptor antagonist drug

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20080709

C20 Patent right or utility model deemed to be abandoned or is abandoned